Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

Nolan, L, Johnson, P W M, Ganesan, A, Packham, G and Crabb, S J (2008) Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential? British Journal of Cancer, 99 (5). pp. 689-694. ISSN 0007-0920

Full text not available from this repository. (Request a copy)

Abstract

Histone deacetylase inhibitors have progressed rapidly from the laboratory to clinical testing. This review highlights the promising data for their combination with a wide range of established and novel anticancer agents and discusses the mechanisms that underpin these interactions.

Item Type: Article
Faculty \ School: Faculty of Science > School of Pharmacy
University of East Anglia > Faculty of Science > Research Groups > Medicinal Chemistry
Faculty of Social Sciences > School of Education and Lifelong Learning
Related URLs:
Depositing User: Deborah Clemitshaw
Date Deposited: 20 Oct 2011 12:44
Last Modified: 25 Jul 2018 05:26
URI: https://ueaeprints.uea.ac.uk/id/eprint/35116
DOI: 10.1038/sj.bjc.6604557

Actions (login required)

View Item